Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 19926 - 19950 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cupric oxide	Approved	CDKN2C	1031	downregulated	cupric oxide results in decreased expression of CDKN2C mRNA	1p32.3	A21783
Cupric oxide	Approved	CEBPG	1054	upregulated	cupric oxide results in increased expression of CEBPG mRNA	19q13.11	A21783
Cupric oxide	Approved	CELF1	10658	upregulated	cupric oxide results in increased expression of CELF1 mRNA	11p11.2	A21783
Cupric oxide	Approved	CENPA	1058	downregulated	cupric oxide results in decreased expression of CENPA mRNA	2p23.3	A21783
Cupric oxide	Approved	CIT	11113	downregulated	cupric oxide results in decreased expression of CIT mRNA	12q24.23	A21783
Cupric oxide	Approved	CKAP2	26586	downregulated	cupric oxide results in decreased expression of CKAP2 mRNA	13q14.3	A21783
Cupric oxide	Approved	CKAP5	9793	downregulated	cupric oxide results in decreased expression of CKAP5 mRNA	11p11.2	A21783
Cupric oxide	Approved	CLCN6	1185	upregulated	cupric oxide results in increased expression of CLCN6 mRNA	1p36.22	A21783
Cupric oxide	Approved	CLDN23	137075	downregulated	cupric oxide results in decreased expression of CLDN23 mRNA	8p23.1	A21783
Cupric oxide	Approved	CLK1	1195	upregulated	cupric oxide results in increased expression of CLK1 mRNA	2q33.1	A21783
Cupric oxide	Approved	CLU	1191	upregulated	cupric oxide results in increased expression of CLU mRNA	8p21.1	A21783
Cupric oxide	Approved	COCH	1690	downregulated	cupric oxide results in decreased expression of COCH mRNA	14q12	A21783
Cupric oxide	Approved	COL4A1	1282	downregulated	cupric oxide results in decreased expression of COL4A1 mRNA	13q34	A21783
Cupric oxide	Approved	COL5A1	1289	downregulated	cupric oxide results in decreased expression of COL5A1 mRNA	9q34.3	A21783
Cupric oxide	Approved	COL5A2	1290	downregulated	cupric oxide results in decreased expression of COL5A2 mRNA	2q32.2	A21783
Cupric oxide	Approved	CPEB4	80315	upregulated	cupric oxide results in increased expression of CPEB4 mRNA	5q35.2	A21783
Cupric oxide	Approved	CREM	1390	upregulated	cupric oxide results in increased expression of CREM mRNA	10p11.21	A21783
Cupric oxide	Approved	CRIPT	9419	upregulated	cupric oxide results in increased expression of CRIPT mRNA	2p21	A21783
Cupric oxide	Approved	CRYAB	1410	upregulated	cupric oxide results in increased expression of CRYAB mRNA	11q23.1	A21783
Cupric oxide	Approved	CSTA	1475	upregulated	cupric oxide results in increased expression of CSTA mRNA	3q21.1	A21783
Cupric oxide	Approved	CTSV	1515	upregulated	cupric oxide results in increased expression of CTSV mRNA	9q22.33	A21783
Cupric oxide	Approved	CYB5R2	51700	upregulated	cupric oxide results in increased expression of CYB5R2 mRNA	11p15.4	A21783
Cupric oxide	Approved	DAPK1	1612	downregulated	cupric oxide results in decreased expression of DAPK1 mRNA	9q21.33	A21783
Cupric oxide	Approved	DBF4	10926	downregulated	cupric oxide results in decreased expression of DBF4 mRNA	7q21.12	A21783
Cupric oxide	Approved	DHRS2	10202	upregulated	cupric oxide results in increased expression of DHRS2 mRNA	14q11.2	A21783

Displaying entries 19926 - 19950 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability